NFKB1 and inflammatory bowel disease: Collectively, our investigation argues that the noncanonical NF-κB pathway targets β-catenin to limit the tolerogenic Raldh2 functions in intestinal DCs, orchestrating local inflammation in colitogenic mice as well as in IBD patients (Fig. 8).